このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Supernus Pharmaceuticals 将来の成長
Future 基準チェック /36
Supernus Pharmaceuticalsは、61.3%と7.3%でそれぞれ年率61.3%で利益と収益が成長すると予測される一方、EPSはgrowで60.7%年率。
主要情報
61.3%
収益成長率
60.7%
EPS成長率
Pharmaceuticals 収益成長 | 23.7% |
収益成長率 | 6.8% |
将来の株主資本利益率 | n/a |
アナリストカバレッジ | Low |
最終更新日 | 10 Sep 2024 |
今後の成長に関する最新情報
Recent updates
Supernus: Stock Slides As Qelbree Sales Questioned, But Positives Still Outweigh Negatives
Sep 12Supernus Pharmaceuticals' (NASDAQ:SUPN) Conservative Accounting Might Explain Soft Earnings
Aug 19Supernus Pharmaceuticals: So-So Neuroscience Portfolio, With ADHD Standout
Jul 02Subdued Growth No Barrier To Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Price
Apr 24Supernus Pharmaceuticals: Moving Through An 'Inflection Year'
Mar 04We Think Supernus Pharmaceuticals (NASDAQ:SUPN) Can Stay On Top Of Its Debt
May 10Does Supernus Pharmaceuticals (NASDAQ:SUPN) Have A Healthy Balance Sheet?
Feb 03These 4 Measures Indicate That Supernus Pharmaceuticals (NASDAQ:SUPN) Is Using Debt Reasonably Well
Oct 19Supernus stock falls 12.6% after FDA declines to approve Parkinson’s disease treatment
Oct 10Supernus Pharmaceuticals: Deep Expertise In CNS, Eyes On Qelbree Launch And Parkinson Portfolio
Aug 19Supernus Pharmaceuticals' (NASDAQ:SUPN) Soft Earnings Are Actually Better Than They Appear
Aug 16Supernus: A Work In Progress
Jul 29Supernus: New Beginnings
Mar 28Brokers Are Upgrading Their Views On Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) With These New Forecasts
Dec 02Is Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Trading At A 34% Discount?
Nov 30Is Supernus Pharmaceuticals (NASDAQ:SUPN) Using Too Much Debt?
Oct 19業績と収益の成長予測
日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
---|---|---|---|---|---|
12/31/2026 | 682 | 38 | 128 | N/A | 4 |
12/31/2025 | 620 | -49 | 92 | 204 | 4 |
12/31/2024 | 620 | 16 | 77 | 203 | 4 |
6/30/2024 | 630 | 5 | 154 | 155 | N/A |
3/31/2024 | 597 | -16 | 100 | 100 | N/A |
12/31/2023 | 608 | 1 | 111 | 111 | N/A |
9/30/2023 | 611 | 26 | 93 | 94 | N/A |
6/30/2023 | 634 | 43 | 71 | 72 | N/A |
3/31/2023 | 668 | 52 | 162 | 162 | N/A |
12/31/2022 | 667 | 61 | 116 | 117 | N/A |
9/30/2022 | 659 | 38 | 138 | 138 | N/A |
6/30/2022 | 630 | 57 | 120 | 120 | N/A |
3/31/2022 | 601 | 73 | 94 | 95 | N/A |
12/31/2021 | 580 | 53 | 125 | 127 | N/A |
9/30/2021 | 564 | 82 | 108 | 110 | N/A |
6/30/2021 | 571 | 100 | 117 | 120 | N/A |
3/31/2021 | 556 | 111 | 163 | 166 | N/A |
12/31/2020 | 520 | 127 | 135 | 138 | N/A |
9/30/2020 | 477 | 129 | 145 | 150 | N/A |
6/30/2020 | 424 | 118 | 177 | 182 | N/A |
3/31/2020 | 402 | 116 | 114 | 119 | N/A |
12/31/2019 | 393 | 113 | 142 | 143 | N/A |
9/30/2019 | 408 | 106 | 131 | 132 | N/A |
6/30/2019 | 409 | 105 | 156 | 157 | N/A |
3/31/2019 | 404 | 103 | 134 | 135 | N/A |
12/31/2018 | 409 | 111 | 128 | 129 | N/A |
9/30/2018 | 381 | 99 | 131 | 132 | N/A |
6/30/2018 | 359 | 87 | 107 | 109 | N/A |
3/31/2018 | 335 | 73 | N/A | 128 | N/A |
12/31/2017 | 302 | 57 | N/A | 115 | N/A |
9/30/2017 | 276 | 58 | N/A | 103 | N/A |
6/30/2017 | 253 | 104 | N/A | 92 | N/A |
3/31/2017 | 228 | 97 | N/A | 83 | N/A |
12/31/2016 | 215 | 91 | N/A | 67 | N/A |
9/30/2016 | 196 | 84 | N/A | 64 | N/A |
6/30/2016 | 179 | 26 | N/A | 35 | N/A |
3/31/2016 | 163 | 18 | N/A | 32 | N/A |
12/31/2015 | 147 | 14 | N/A | 35 | N/A |
9/30/2015 | 135 | 11 | N/A | 18 | N/A |
6/30/2015 | 118 | 5 | N/A | 14 | N/A |
3/31/2015 | 112 | 5 | N/A | -6 | N/A |
12/31/2014 | 93 | -11 | N/A | -24 | N/A |
9/30/2014 | 72 | -37 | N/A | -40 | N/A |
6/30/2014 | 50 | -59 | N/A | -51 | N/A |
3/31/2014 | 21 | -89 | N/A | -60 | N/A |
12/31/2013 | 12 | -92 | N/A | -58 | N/A |
9/30/2013 | 3 | -83 | N/A | -65 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: SUPNの予測収益成長率 (年間61.3% ) は 貯蓄率 ( 2.5% ) を上回っています。
収益対市場: SUPNの収益 ( 61.3% ) はUS市場 ( 15% ) よりも速いペースで成長すると予測されています。
高成長収益: SUPNの収益は今後 3 年間で 大幅に 増加すると予想されています。
収益対市場: SUPNの収益 ( 7.3% ) US市場 ( 8.7% ) よりも低い成長が予測されています。
高い収益成長: SUPNの収益 ( 7.3% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: SUPNの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です